Sale!

FGF12 Gene Early infantile epileptic encephalopathy type 47 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGF12 gene, associated with early infantile epileptic encephalopathy type 47 (EIEE47), plays a crucial role in the normal development and function of the nervous system. Mutations in the FGF12 gene can lead to severe neurological conditions characterized by early-onset seizures, developmental delays, and various other neurological abnormalities. Given the critical nature of timely and accurate diagnosis for managing such conditions, genetic testing for mutations in the FGF12 gene becomes indispensable.

DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the FGF12 gene to confirm a diagnosis of early infantile epileptic encephalopathy type 47. This test is particularly vital for families with a history of the condition or for infants presenting symptoms consistent with EIEE47. Early diagnosis through this genetic test can facilitate prompt intervention and management strategies, potentially improving outcomes and quality of life for affected individuals.

The cost of the FGF12 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the FGF12 gene that could be indicative of EIEE47. Conducted in a state-of-the-art laboratory by experienced geneticists, the test adheres to stringent quality and accuracy standards, ensuring reliable results for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47 Genetic Test

Test Name: FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47.

Test Details

The FGF12 gene is associated with early infantile epileptic encephalopathy type 47 (EIEE47), a rare genetic disorder characterized by seizures that begin in the first few months of life. EIEE47 is caused by mutations in the FGF12 gene, which provides instructions for making a protein that is involved in the regulation of neuronal excitability.

NGS (next-generation sequencing) genetic testing can be used to analyze the FGF12 gene and identify mutations that may be causing EIEE47. This type of testing uses advanced sequencing technology to rapidly analyze large amounts of genetic data and identify variations in the DNA sequence.

NGS genetic testing for EIEE47 can help to provide a definitive diagnosis for affected individuals, which can be important for guiding treatment decisions and providing appropriate medical care. It can also be used for carrier testing and prenatal diagnosis in families with a history of EIEE47.

Test Name FGF12 Gene Early infantile epileptic encephalopathy type 47 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGF12 Gene Early infantile epileptic encephalopathy type 47 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FGF12 Gene Early infantile epileptic encephalopathy type 47
Test Details

The FGF12 gene is associated with early infantile epileptic encephalopathy type 47 (EIEE47), a rare genetic disorder characterized by seizures that begin in the first few months of life. EIEE47 is caused by mutations in the FGF12 gene, which provides instructions for making a protein that is involved in the regulation of neuronal excitability.

NGS (next-generation sequencing) genetic testing can be used to analyze the FGF12 gene and identify mutations that may be causing EIEE47. This type of testing uses advanced sequencing technology to rapidly analyze large amounts of genetic data and identify variations in the DNA sequence.

NGS genetic testing for EIEE47 can help to provide a definitive diagnosis for affected individuals, which can be important for guiding treatment decisions and providing appropriate medical care. It can also be used for carrier testing and prenatal diagnosis in families with a history of EIEE47.